clinafloxacin has been researched along with Infectious Skin Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christou, N; Eiseman, I; Siami, G; Tack, KJ | 1 |
| LaFleur, BJ; Siami, FS; Siami, GA | 1 |
2 trial(s) available for clinafloxacin and Infectious Skin Diseases
| Article | Year |
|---|---|
Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fluoroquinolones; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Skin Diseases, Infectious; Tazobactam | 2001 |
Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Dermatitis, Phototoxic; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Hospitals, Veterans; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Skin Diseases, Infectious; Soft Tissue Infections; United States | 2002 |